These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8443964)

  • 21. Hypocomplementaemia in a newborn caused by transplacental passage of maternal autoantibody with C3 nephritic factor (C3 NeF) activity.
    Weiss L; Rougier N; Blouin J; Kazatchkine MD; Lhotta K; König P
    Nephrol Dial Transplant; 1995 Dec; 10(12):2374. PubMed ID: 8808251
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of the classic complement pathway in patients with the C3 nephritic factor.
    McLean RH; Siegel NJ; Kashgarian M
    Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.
    Ibrahim ST; Chinnadurai R; Ali I; Payne D; Rice GI; Newman WG; Algohary E; Adam AG; Kalra PA
    PLoS One; 2020; 15(1):e0228101. PubMed ID: 32004338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement C3 and its polymorphism: biological and clinical consequences.
    Delanghe JR; Speeckaert R; Speeckaert MM
    Pathology; 2014 Jan; 46(1):1-10. PubMed ID: 24300728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological features of patients affected by Barraquer-Simons syndrome.
    Corvillo F; Ceccarini G; Nozal P; Magno S; Pelosini C; Garrido S; López-Lera A; Moraru M; Vilches C; Fornaciari S; Gabbriellini S; Santini F; Araújo-Vilar D; López-Trascasa M
    Orphanet J Rare Dis; 2020 Jan; 15(1):9. PubMed ID: 31924231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
    Elmgreen J; Sørensen H; Berkowicz A
    Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allotypic variants of human C3 and properdin factor B in two French populations Normans and Basques.
    Davrinche C; Rivat C; Rivat-Peran L
    Rev Fr Transfus Immunohematol; 1981 Jun; 24(3):309-17. PubMed ID: 6912604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ; Vázquez Martul M; Ecija Peiró JL; González Pérez J; Lirio Rodríguez J; González Mediero I
    An Esp Pediatr; 1989 Jun; 30(6):499-502. PubMed ID: 2679278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
    [No Abstract]   [Full Text] [Related]  

  • 31. C3F gene mutation is involved in the susceptibility to pre-eclampsia.
    Rhim MS; Meddeb S; Kaabia O; Jalloul M; Sakouhi M; Jrzad BB; Felah R
    Arch Gynecol Obstet; 2015 May; 291(5):1023-7. PubMed ID: 25322978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional consequences of the genetic polymorphism of the third component of complement.
    Welch TR; Beischel L; Kleesattel A
    J Pediatr; 1990 May; 116(5):S92-7. PubMed ID: 2139466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal complement synthesis in glomerulonephritis.
    Ravnskov V
    Lancet; 1994 Jan; 343(8891):235-6. PubMed ID: 7904688
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-factor B autoantibody in dense deposit disease.
    Strobel S; Zimmering M; Papp K; Prechl J; Józsi M
    Mol Immunol; 2010 Apr; 47(7-8):1476-83. PubMed ID: 20193965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and inheritance of C3 types in the Polish population.
    Schlesinger D; Mańczak M; Hałasa J
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):277-83. PubMed ID: 444041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha chain of the complement component, C3.
    Poznansky MC; Clissold PM; Lachmann PJ
    J Immunol; 1989 Dec; 143(11):3860-2. PubMed ID: 2584723
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistent low C3 levels associated with meningococcal meningitis and membranoproliferative glomerulonephritis.
    Fernandez-Sola J; Monforte R; Ponz E; Lozano F; Plana M; Montoliu J; Torras A; Ingelmo M
    Am J Nephrol; 1990; 10(5):426-30. PubMed ID: 2127874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3 polymorphism in Greece.
    Germenis A; Kolitsopoulos A; Dimopoulos AM; Fertakis A
    Hum Hered; 1985; 35(2):123-5. PubMed ID: 3988299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.